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Abstract: The CS-αβ architecture is a structural scaffold shared by a high number of small, cationic, 
cysteine-rich defense peptides, found in nearly all the major branches of the tree of life. Although 
several CS-αβ peptides involved in innate immune response have been described so far in bivalve 
mollusks, a clear-cut definition of their molecular diversity is still lacking, leaving the evolutionary 
relationship among defensins, mytilins, myticins and other structurally similar antimicrobial 
peptides still unclear. In this study, we performed a comprehensive bioinformatic screening of the 
genomes and transcriptomes available for marine mussels (Mytilida), redefining the distribution of 
mytilin-like CS-αβ peptides, which in spite of limited primary sequence similarity maintain in all 
cases a well-conserved backbone, stabilized by four disulfide bonds. Variations in the size of the 
alpha-helix and the two antiparallel beta strand region, as well as the positioning of the cysteine 
residues involved in the formation of the C1–C5 disulfide bond might allow a certain degree of 
structural flexibility, whose functional implications remain to be investigated. The identification of 
mytilins in Trichomya and Perna spp. revealed that many additional CS-αβ AMPs remain to be 
formally described and functionally characterized in Mytilidae, and suggest that a more robust 
scheme should be used for the future classification of such peptides with respect with their 
evolutionary origin. 
Keywords: bivalves; mussels; antimicrobial peptides; innate immunity; defensins 
 
1. Introduction 
Antimicrobial peptides (AMPs) are fundamental effector molecules of the innate immune 
system, which are present in nearly all living organisms, serving as a first line of defense against 
pathogens in the humoral immune response. AMPs have acquired a role of primary importance along 
the evolution of invertebrate metazoans, which lack an immunoglobulin-based adaptive immune 
system and have developed a larger and more diversified repertoire of innate immune molecules 
compared with vertebrates. Some filter-feeding aquatic organisms, such as bivalve mollusks, seem to 
have developed a remarkably rich arsenal of AMPs and other defense peptides, which might be 
interpreted as a strategy to efficiently manage bacterial infections from opportunist pathogens found 
in the water column [1]. 
The history of AMP research in mollusks has been always linked with marine mussels (Mytilus 
spp.), starting from the identification of several short cysteine-rich peptides from active hemolymph 
fractions of Mytilus galloprovincialis and Mytilus edulis in the mid-90s [2,3]. Over the following years, 
several experimental studies have clarified many aspects concerning the biological function, the 
regulation and the spectrum of activity of these antimicrobial molecules. Early reports revealed that 
most mussel AMPs are produced as inactive precursors and stored in granules within hemocytes, the 
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main circulating cells with immune functions (i.e., phagocytosis, encapsulation of invading 
pathogens and production of cytotoxic molecules) in mollusks [4]. Albeit with different strength and 
specificity, all mussel AMPs were found to be active against Gram-positive and Gram-negative 
bacteria and, in some cases, also against viruses, fungi and protozoans [2–6]. However, recent studies 
have also evidenced that some mussel AMPs, most notably myticins, also display cytokine-like 
properties [7]. 
The sequence diversity of the AMPs isolated from mussel hemolymph made immediately clear 
that they belonged to distantly related—or even completely unrelated—groups. Indeed, while some 
of them were similar to previously described insect defensins [8,9], others did not bear significant 
homology with any other known sequence, and were therefore assigned different names. In spite of 
a lack of primary sequence similarity, three of these AMP families (i.e., defensins, mytilins and 
myticins) were characterized by the presence of eight cysteine residues, involved in the formation of 
four disulfide bonds, which stabilize the mature peptide in a compact, cationic and amphipathic 
structure [10]. 
Moreover, the 3D structures of the mussel defensins and mytilins, experimentally determined 
by NMR, revealed that these two AMP classes adopted a similar cysteine-stabilized alpha helix/beta-
sheet (CS-αβ) three-dimensional folding, comprising a single alpha helix and two anti parallel beta 
strands, with the four expected disulfide bonds engaged in a C1-C5, C2-C6, C3-C7 and C4-C8 array 
[11,12]. Although the structure of myticins has not been experimentally determined yet, structural 
modeling approaches suggests that these AMPs may also bear a similar CS-αβ fold, stabilized by the 
same disulfide array described above [13]. 
Besides mussel AMPs, the CS-αβ motif, stabilized by either three or four disulfide bonds, is 
found in several other peptides with toxic and defense functions, which display a widespread 
distribution in nature and little to no primary sequence homology with each other. The remarkable 
structural similarity among CS-αβ peptides from distantly related taxa led some authors to propose 
a common origin from an ancestral prototypical sequence [14]. In mussels, this hypothesis is further 
supported by the similar gene architecture of all known CS-αβ AMPs, as well as by the similar 
tripartite organization of the precursor peptides [10]. 
In the present manuscript, we focused our attention on mytilins, one out of the three mussel 
hemocyte-specific CS-αβ AMP families described so far. Like other mussel AMPs, mytilins show a 
more potent anti-bacterial activity against Gram+ bacteria (displaying a MIC as low as 0.6 µM against 
some strains) compared with Gram– bacteria, which are generally only affected at significantly higher 
concentrations. Mytilins have been identified both in granular hemocytes, recruited at infection sites, 
and in plasma, suggesting that these AMPs have a primary role in killing invading bacteria upon 
phagocytosis, and a secondary systemic role exerted by the fraction of the peptide released in the 
plasma [15,16]. 
Mytilin genes comprise four exons and three introns [17] and encode precursor peptides whose 
structure can be summarized as follows (Figure 1): (i) a N-terminal signal peptide (SP), which targets 
the precursor to the secretory pathway; (ii) a core region corresponding to the mature, cysteine-rich, 
cationic and biologically active peptide and (iii) an anionic C-terminal extension, which may facilitate 
the 3D folding of the mature peptide region and neutralize the positive charge of the mature peptide 
until its release from storage granules. 
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Figure 1. Secondary structure, isoelectric point distribution, sequence conservation logo and disulfide 
bridge array for mytilin B, C, D and G1 of Mytilus galloprovincialis. The isoelectric point plot was 
generated with a sliding window size of 15 amino acids. The secondary structure of the mature 
peptide region reports experimental data obtained for mytilin B (PDB: 2EEM). 
Four major types of mytilins have been described in M. galloprovincialis, i.e., mytilin B (and its 
allelic variant F), C, D and G1, which are all characterized by a C-X (3)-C-X (3)-C-X (4)-C-X (11)-C-X-
C-X-C-X (2)-C cysteine array and display a modest level of inter-individual sequence variability 
compared with other mussel AMPs [18]. More recently, three additional sequences have been added 
to the family: mytilin K and N display some unique features, such as a longer loop between C1 and 
C2, paired with the unusual position of C5. In spite of the presence of a canonical cysteine array, the 
primary sequence of the third new mytilin, named pseudomytilin, was largely divergent, in 
particular in the C-terminal extension region [10]. 
Although mytilins are most certainly present in the other inter-fertile species of the Mytilus edulis 
species complex [3,19,20], as well as in other species of the same genus, such as a Mytilus coruscus 
[21,22], to date they have never been reported in other species of the order Mytilida. Nevertheless, 
the evolutionary relatedness of all marine mussels and their adaptation to similar coastal 
environments suggests that other unexplored species may harbor a similarly complex complement 
of AMPs, which may also include mytilin-like peptides. 
The application of next generation sequencing to the Mytilidae [23,24], in particular thanks to 
the feasibility of whole genome sequencing approaches [25–27], now offers new opportunities for the 
discovery of novel AMP sequences in species that have been so far subjected to limited scientific 
attention. In the present work we describe for the first time the presence of mytilin-like sequences in 
two new genera, i.e., Perna Philipsson 1788 and Trichomya Ihering 1900, which implies the possibility 
that related sequences might be found in other phylogenetically related species in the near future. 
Moreover, we discuss the evolutionary relationship between the newly identified and previously 
known sequences, report the 3D structural prediction of the newly identified sequences obtained by 
threading and propose a hidden Markov model (HMM) for the future identification of mytilin-like 
peptides, which might also aid their discrimination from other structurally similar mussel CS-αβ 
peptides. 
2. Results and Discussion 
2.1. Taxonomic Distribution of Mytilin-Like AMPs 
The iterative screening approach of all the -omic data available for species pertaining to the 
family Mytilidae (see Section 3.1) allowed the identification of mytilin-like sequences in three genera, 
i.e., Mytilus Linnaeus 1758, Perna Philipsson 1788 and Trichomya Ihering 1900. While mytilins have 
been previously reported and studied extensively in Mytilus spp. during the past two decades 
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[4,10,12,15,17,19–21,24], to the best of our knowledge this is the first report of the occurrence of this 
AMP family in other genera of marine mussels. 
In order to appropriately discuss the evolutionary implications of this finding, we need to point 
out that the phylogenetic relationship among Mytilidae are still a matter of debate and subject to 
change. Indeed, recent molecular approaches have challenged the classical taxonomical classification 
of these organisms, revealing that morphology- and genetics-based phylogeny of mussels often show 
inconsistencies [28,29]. Nevertheless, the placement of some taxa is now starting to emerge with more 
clarity from the consensus of the most up-to-date studies. For this purpose, here we will make 
reference to the phylogenetic analysis recently produced by Morton and colleagues [29], which 
identified two major evolutionary lineages (clade A and B) within Mytilidae. At the same time, will 
also discuss our findings in light of the currently accepted classification, as exemplified by 
MolluscaBase [30]. 
All the three genera where mytilin sequences were identified belong to one of the two major 
evolutionary lineages identified by Morton and colleagues, i.e., clade A. Although Trichomya is 
currently considered as a member of the subfamily Septiferinae [30], recent molecular data support 
its close relatedness to Mytilus, suggesting that this genus should be placed within the subfamily 
Mytilinae [25,29]. In light of this observation, the presence of mytilins in Trichomya would be 
consistent with a shared ancestry with the Mytilus genus. 
The phylogenetic relatedness between Perna and Mytilus has been already recognized and 
accepted, since both genera are considered part of the Mytilinae subfamily [30]. However, molecular 
evidence suggest that this genus should be reconsidered as a member of the subfamily Musculinae, 
closely related to the subfamily Septiferinae, which are both sister taxa to Mytilinae. Even though our 
screening was limited to the few mussel species with available -omic data, these findings imply that 
mytilins are likely be also present in other genera belonging to Musculinae and Septiferinae, such as 
Musculus Röding 1798, Musculista Yamamoto and Habe 1958, Septifer Récluz, 1848 and possibly many 
others that still await a revised classification. 
In stark contrast, no mytilins were found in the transcriptomes available for the most basal 
subfamilies of clade A, including Brachidontinae, Mytiliseptiferinae and Lithophaginae clade 2 (i.e., 
Lithophaga Röding, 1798). Although the missed detection of mytilins in these taxa could be explained 
by the lack of expression, this hypothesis seems unlikely due to availability of a large amount of data 
from multiple species and tissues [28,31,32]. 
No mytilin-like sequences were identified in any species pertaining to the clade B from Morton 
et al., which includes hydrothermal vent deep-sea mussels (subfamily Bathymodiolinae), 
horsemussels (subfamily Modiolinae), one clade of rock-boring mussels (Leiosolenus Carpenter 1857, 
currently considered part of the Lithophaginae subfamily), the invasive mussels Xenostrobus B. R. 
Wilson 1967 and Limnoperna Rochebrune 1882 (both currently considered part of the Arcuatulinae 
subfamily). The availability of three fully sequenced genomes for this clade, i.e., Bathymodiolus 
platifrons, Limnoperna fortunei and Modiolus philippinarum [26,27], rules out the possibility of a missed 
detection due to lack of expression. 
In light of these observations, and based on the assumption that all mussel CS-αβ AMPs share a 
common origin from a single defensin-like ancestral prototypical gene (see the Introduction), mytilins 
might have been originated by a gene duplication event that mostly likely occurred in clade A 
Mytilidae (Morton et al., 2019) after the split between the Mytilidae/Musculidae/Septiferinae and the 
Brachidontinae/Septiferinae clades (Figure 2). As it will be discussed in Section 2.3, pseudomytilins 
are expected to represent a relatively “young” Mytilus-specific group of mytilin-derived sequences. 
The evolutionary origins of myticins, which might also share the same ancestry, will be not discussed 
in the present work. 
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Figure 2. Hypothetical evolutionary scenario of the Mytilidae CS-αβ antimicrobial peptides, based on 
the presence/absence patterns observed in publicly available -omic data. In brief, an ancestral 
defensin-like gene is expected to have supported the prototypical structural scaffold for the 
development of all the CS-αβ AMPs currently found in extant mussel species. Mytilins are expected 
to have been originated by a gene duplication event that might have occurred within clade B (see 
Morton et al., 2019), after the split between Brachidontinae and Mytiseptiferinae from the other three 
subfamilies. The evolutionary origin of pseudomytilins is expected to have occurred much more 
recently, possibly soon after the split between the Mytilus and Trichomya lineages. 
2.2. Analysis of Novel Mytilin Sequence Precursors 
The different species included in the Mytilus edulis complex (i.e., M. edulis, M. galloprovincialis, 
M. trossulus, M. chilensis and M. planulatus) are evolutionarily closely related and locally subject to 
hybridization, which results in the broadly documented phenomena of genetic introgression [33]. In 
the present work, we chose to adopt a stringent protocol for reporting “novel” sequences, here 
defined as those sharing <95% primary sequence identity with those previously identified by other 
studies, using M. galloprovincialis as a reference for discussion. This approach was chosen to 
exclusively consider sequences, which might have evolutionary relevance, disregarding minor intra- 
and inter-specific variants that are expected to be found in large numbers in Mytilus populations. 
Overall, we identified two novel mytilin full-length sequences in the M. galloprovincialis 
transcriptome. The first one, named mytilin M, shared the highest level of homology with mytilin B 
(73% sequence identity). Its 101 aa long precursor peptide had a signal peptide slightly shorter than 
the other M. galloprovincialis mytilins (20 aa) and was characterized by a 34 aa long mature peptide, 
with the canonical 8 cysteine-disulfide array (Figure 3). The second sequence, mytilin L closely 
resembled mytilin N (80% sequence identity) and presented an alternative cysteine array compared 
with canonical mytilins, which is also found in the K isoform. The 39 aa long mytilin L mature peptide 
displayed an unusually long loop between C1 and C2 (7 aa), paired with an unusual position of C5 
(Figure 3). The possible implications of these unique features on the topology of the C1–C5 disulfide 
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bond will be discussed in detail in Section 2.5. Like all the other Mytilus mytilins, the predicted mature 
peptide of both MytL and MytM were highly cationic, with a +9 positive net charge (Figure 4A). 
 
Figure 3. Multiple sequence alignment of full-length mytilins precursor peptides. The signal peptide, 
mature peptide and C-terminal anionic extension regions are highlighted. Residues conserved in 
>50% sequences are shaded and the cysteine residues possibly engaged in disulfide bonds are marked 
with a red background. Note that some nearly identical sequences have been omitted from the 
alignment for simplicity’s sake. PM: pseudomytilin; Mcal: M. californianus; Mcor: M. coruscus; Mgal: 
M. galloprovincialis; Pcan: Perna canaliculus; Pvir: P. viridis. 
 
Figure 4. Average isoelectric point, calculated based on a sliding window of 15 aa for M. 
galloprovncialis (panel A), M. coruscus (panel B), M. californianus (panel C) and T. hirsuta (panel D) 
mytilins. The vertical bars indicate the division between the signal peptide, mature peptide and C-
terminal extension regions (see Figure 3). 
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We could also identify mytilin sequences in two additional species of the Mytilus genus, which 
are not part of the M. edulis species complex, i.e., M. californianus and M. coruscus. Although several 
mytilins had been previously identified in M. coruscus [21,22], we can here report a novel sequence, 
named mytilin-9. This 101 aa long precursor sequence, processed into a 34 aa long mature peptide, 
shared significant similarity with other variants found in the same species (68% sequence identity, 
see Figure 3) and displayed a sharp shift in charge distribution between the cationic mature peptide 
region and the anionic C-terminal extension (Figure 4B). 
A total of six different mytilin sequences were identified in M. californianus, representing the first 
report of this AMP family in the species. In general, these sequences showed a higher level of 
similarity with the mytilins from M. coruscus (in the range of 78–87%) than with those found in the 
M. edulis complex, consistently with the phylogenetic placement of the species [25]. The length of the 
precursor and mature was very similar (102–106 aa and 34–35 aa, respectively), and all sequences 
displayed a canonical cysteine array (Figure 3). As previously described for the M. galloprovincialis 
mytilins, a sharp shift in the amino acidic composition of the precursor protein was visible in 
correspondence with the predicted mature peptide cleavage site, highlighting a clear distinction 
between the positively charged mature region and the negatively charged C-terminal extension 
(Figure 4C). 
We were also able to identify a few additional sequences closely related with pseudomytilin [10]. 
In detail, pseudomytilins were found in M. galloprovincialis (two sequences in addition to the one 
previously reported) and M. californianus (one sequence). While the M. californianus sequence 
displayed an apparently truncated C-terminal extension, the two M. galloprovincialis precursor 
peptides had a similar precursor and mature peptide length (92–95 aa and 43 a, respectively, see 
Figure 3). Compared with the other mytilin-like sequences described so far, the high positive net 
charge of the mature peptide (+8/+10) was not matched by the anionic C-terminal extension, which 
only displayed a weak negative charge. 
We identified three mytilin sequences in T. hirsuta, with a precursor length of 102–106 aa and 
32–34 aa long predicted mature peptides with canonical cysteine arrays (Figure 3), similar to those of 
Mytilus (i.e., 46–69%, see Figure 3). The mature peptides displayed a positive total net charge (+7/+10), 
which was counterbalanced by the negative charge of the anionic C-terminal extension (−6/−8; Figure 
4D). 
A much higher number of mytilin-like sequences were found in two distinct species of the Perna 
genus, i.e., the Asian and New Zealand green mussels Perna viridis (seven variants) and Perna 
canaliculus (eight variants). All the precursor proteins were 83–90 aa long, with a 33–37 aa long 
predicted mature peptide and a C-terminal extension that did not bear a remarkable primary 
sequence similarity with those of Mytilus and Trichomya (Figure 3). Although, like the other mytilins, 
those found in Perna usually displayed a charge separation between the mature peptide and the C-
terminal extension, the cationicity of the mature peptides was of minor entity, with some extreme 
cases showing nearly neutral charge at pH 7. In detail, the two regions averaged a net charge equal 
to +4.33 (ranging from 0 to +11) and −3.4 (ranging from 0 to −7), respectively. 
The most peculiar feature of Perna mytilins was that 13 of the 15 sequences identified had an 
extra cysteine residue placed between the C6 and C7 of the canonical array. This resulted in the 
presence of an odd number of cysteine residues and in the creation of an unusual “CCC” motif, whose 
possible functional implications will be discussed in Section 2.5. At the same time, many Perna 
mytilins were characterized by an alternative disulfide array, similar to the one found in M. 
galloprovincialis mytilin K, L and N, due to variation in the position of C5 (Figure 3). It needs to be 
further noted that one mytilins from P. viridis lacked the C8 of the canonical array. 
All the novel sequences identified in the present study have been deposited in GenBank under the 
accession IDs: MN883571–MN883600. The mature peptide primary sequences are listed in Table 1. 
Table 1. List of the novel mytilin sequences identified in this study. Cysteine residues are highlighted 
in bold. PM: pseudomytilin; Mcal: M. californianus; Mcor: M. coruscus; Mgal: M. galloprovincialis; Pcan: 
P. canaliculus; Pvir: P. viridis. 
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Sequence Name Mature Peptide Sequence Length (aa) Net Charge 
Mcal mytilin 1 SCASRCKYRCRARRCRYYVSVRYGWFCYCRCLHC 34 +9 
Mcal mytilin 2 SCASRCKSRCRARRCKYYVSVRYGWFCYCRCLRC 34 +10 
Mcal mytilin 3 SCALLCKAHCRARRCGYYVSVFYHGRCYCRCLRC 34 +7 
Mcal mytilin 4 SCASKCKAVCRRRRCAGYDWVLWGGHCFCKCSRC 34 +7 
Mcal mytilin 5 SCASRCKYRCRRRRCRSYVAVRYCCRCLCKCRRC 34 +13 
Mcal mytilin 6 SCIPRCKYICTRRRRCGYYAAIYYCHRCYCKCLSC 35 +8 
Mcal PM SCRTRCRFKCFGRGCGAYFAAQYGDFCYCKCYRC 34 +6 
Mcor mytilin 9 SCASRCKSRCRARRCRYYVAVRYGWFCYCRCLRC 34 +10 
Mgal mytilin L YCPQSFRRICSSRCRGRGCQYYVAVCFPRRYYCKCLRC 38 +9 
Mgal mytilin M SCASRCRSHCRARRCHYSKSVLVGRRCFCKCFLC 34 +9 
Mgal PM 2 SCRTRCRLKCFGRGCGAYFAAQRGPFCLCKCYRC 34 +8 
Mgal PM 3 SCRSRCRWKCFRRRCGAYFAAQRGPFCLCKCYRC 34 +10 
Pcan mytilin 1 SCDRWCNTSCYNKGCRYYAASVSDGRCFCCCITC 34 +2 
Pcan mytilin 2 NCARSCSSRCYHRNCKAYASVYRNETCYCCCIDC 34 +3 
Pcan mytilin 3 SCATSCSSRCEYRKCEDYASAIRDGKCYCCCIKC 34 +2 
Pcan mytilin 4 NCFSCPSTCARRGCRYFACATRLRKSYCCCFVC 33 +6 
Pcan mytilin 5 SCFSCPRTCGARGCRYYACATRFGTSYCCCFKC 33 +5 
Pcan mytilin 6 YCDLCRWYCSNKGCAYYLCGNKFGNNYCCCFKC 33 +3 
Pcan mytilin 7 YCDRCREYCSNTGCGYYMCVRRIVDRRLKYYCCCFKC 37 +5 
Pcan mytilin 8 GCGGCKYKCRRRGCRGYVCYKKRWLTICKCFRC 33 +11 
Pvir mytilin 1 SCATSCSSRCYNKGCKYYAAAIRSGTCYCCCFKG 34 +5 
Pvir mytilin 2 SCSSCPRTCGARGCRYYACATRLGTSYCCCFKC 33 +5 
Pvir mytilin 3 DCDSNCNHRCYYRGCKAYASALNNGTCYCCCVDC 43 0 
Pvir mytilin 4 SCARCKDHCRNKGCGFYMCVLRYGTYYCCCFKC 33 +5 
Pvir mytilin 5 NCERCKYYCSYKNCSQYMCVRHNANDYCCCFNC 33 +2 
Pvir mytilin 6 ACDRCKAYCTIKGCGYYLCVHRFPSYYCCCFKC 33 +4 
Pvir mytilin 7 SCYTCKRRCAARGCRYYLCVIRYYRVYCGCYRC 33 +8 
Thir mytilin 1 SCSSICRYRCRRCRGFIWINIFGRCYCKCYGC 32 +7 
Thir mytilin 2 SCASSCKSRCRSRGCKYFVSVRYRYHCYCKCLRC 34 +9 
Thir mytilin 3 SCASRCKSRCRARRCKYYVSVRYGWFCYCKCLRC 34 +10 
2.3. Molecular Evolution of Mytilins 
The JTT + I + G4 rate heterogeneity model of molecular evolution (i.e., the one proposed by Jones, 
Taylor and Thornton [34], with a proportion of invariant sites and Gamma-distributed rate of variation 
across sites) was identified as the best fitting one for mytilins. The Bayesian tree (Figure 5) showed a 
sharp and highly supported separation between the mytilins from Mytilus and Thricomya spp. and those 
from Perna spp. (100% posterior probability support). Based on the hypothesized derivation of mytilins 
from an ancestral defensin-like gene (see Figure 2), this hypothetical sequence would be expected to 
occupy a basal position in the tree. 
The mytilins from Perna displayed a remarkable diversification, with a subdivision between two 
divergent clades shared by both P. viridis and P. canaliculus. This subdivision, supported by a highly 
significant posterior probability values (93%, see Figure 5), mirrored the visible primary sequence 
divergence of the C-terminal extension (see Figure 3), but did not match the presence of a canonical 
or alternative cysteine array (see Section 2.2). Overall, the phylogenetic tree indicates that the 
ancestral Perna mytilin gene might have undergone an initial duplication very early along the 
evolution of the genus, and further implies that the mytilin CS-αβ structural scaffold allows a large 
degree of freedom concerning the position of C5, which has been independently modified in 
sequences belonging to both the Perna and the Mytilus lineages, generating an alternative disulfide 
array (Figures 3 and 5), whose implications will be discussed in Section 2.5. 
All the Mytilus and Trichomya spp. mytilins were placed, intermixed, in a well supported 
monophyletic clade (96% posterior probability, see Figure 5), and overall displayed a lower level of 
molecular diversity compared with Perna. The sequences from the different Mytilus species were 
often mixed, consistently with their hypothesized recent origin by gene duplication, as well as with 
the proven dispensable nature of some M. galloprovincialis mytilin genes [25]. The Bayesian tree also 
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indicated the derivation of pseudomytilins from canonical mytilins, as suggested by their placement 
in a divergent highly supported early-branching clade (100% posterior probability, see Figure 5). 
Although no pseudomytilins have been identified in T. hirsuta, the topology of the tree suggests that 
this absence might be simply due to a lack of expression in the few transcriptomic datasets available 
for this species (Figure 2). 
The multiple sequence alignment of all mytilins (Figure 3) clearly identified the extreme 
sequence divergence of the C-terminal anionic extension region as a key factor in determining the 
placement of the precursor peptides in the four evolutionary lineages evidenced in Figure 5. This 
observation may be consistent with the “exon shuffling” hypothesis, previously postulated by other 
authors for the genes encoding defensin-like antimicrobial peptides [35]. This evolutionary model 
would imply the independent recruitment along evolution by the central CS-αβ module of different 
and unrelated upstream or downstream sequences. However, we argued that alternative scenarios, 
such as more relaxed selective constraints acting on the C-terminal region, might have produced 
similar results. The future analysis of additional genomes from Mytilidae is certainly expected to 
clarify the possible impact of exon shuffling on mytilin gene evolution. 
 
Figure 5. Bayesian tree built from all mytilin-like sequences, based on a JTT + I + G model of molecular 
evolution (see Section 3.4). Nodes below 50% support were collapsed. PM: pseudomytilin; Mcal: M. 
californianus; Mcor: M. coruscus; Mgal: M. galloprovincialis; Pcan: P. canaliculus; Pvir: P. viridis. For a 
definition of the canonical and alternative cysteine array, see Section 2.2. 
2.4. Building of a Mytilin-Specific Hidden Markov Model 
Antibiotics 2020, 9, 37 10 of 17 
Here we proposed a new mytilin-specific HMM, built by exploiting the improved knowledge 
derived from the discovery of the novel sequences presented in the present work, which might 
provide a support for the future identification of additional mytilin sequences in the genomes, 
transcriptomes and proteomes of other mussel species where mytilins are expected to be found (see 
Section 2.1). 
The construction of the HMM (available in Supplementary File S1) was based on 39 unique 
sequences, selected with a clustering approach (see Section 3.3). This allowed the removal of 
redundant, nearly identical sequences, enabling a balanced representation of the remarkable 
sequence variation shown in Figures 3 and 5. 
The test of the HMM model revealed a high level of sensitivity, as it was able to identify with 
significant e-values (i.e., lower than 1 × 10-10) all the mytilin peptides described in the present work 
(Supplementary Table S1). The specificity of the method was also tested by screening the full set of 
sequences analyzed in this work, which included previously known sequences of other mussel CS-
αβ AMPs. We observed that this method produced a few false positives, mostly belonging to the 
myticin AMP family, even though the e-values associated with such matches were generally close to 
the arbitrary threshold of significance (0.05). Due to the evolutionary and structural link between the 
two Mytilus AMP families (see the Introduction), this result was expected. We suggest that the HMM 
search for mytilin sequences should be always paired with a parallel screening performed with a 
myticin-specific HMM. Preliminary tests indicate that this strategy would allow a reliable 
discrimination between the two AMP families (Supplementary Table S1). 
2.5. Structural Prediction 
Our threading approach succeeded in building reliable three-dimensional structural models for 
nearly all the primary sequence analyzed, with the only exception of two sequences from Perna spp., 
whose models were poorly supported (Supplementary Table S2). All the predicted models displayed 
a very similar structure and shared the CS-αβ backbone, with the only exception of pseudomytilins, 
where the two β-strands were modeled as coils. This result may be consistent with the inaccuracies 
typically linked with β-sheet prediction [36], and therefore it should not be considered as an 
indication that pseudomytilins are lacking these secondary structures. 
Despite their high primary sequence divergence (Figure 3), the mytilins from Perna and 
Mytilus/Trichomya models were almost overlapping (see Figure 6A as an example). However, the 
variable position of C5 in most Perna and some Mytilus mytilins (see Section 2.2) had a significant 
effect on the topology of the disulfide array, with important structural (and possibly also functional) 
implications. For example, the predicted models from Perna could be divided between two well-
distinct structural subgroups, which were fully consistent with the two alternative arrays highlighted 
in Section 2.2 (see Figure 5). In detail, the first subgroup included all the Perna mytilins characterized 
by the canonical cysteine array: in this case, the C1–C5 disulfide bond was predicted to connect the 
α-helix with the second β-strand of the CS-αβ fold (Figure 6B), perfectly matching the disulfide 
connectivity previously described for M. galloprovincialis mytilin B [11] (Figure 6D). On the other 
hand, the second subgroup comprised all the Perna mytilins characterized by the presence of an 
alternative cysteine array. In these sequences, the C1–C5 disulfide bond was predicted to link the α-
helix with the first β-strand, where C5 was located (Figure 6C,E). Strikingly, the C1–C5 disulfide bond 
of the three M. galloprovincialis sequences with an alternative cysteine array (mytilin L, K and N, see 
Figures 3 and 5) was also placed in a similar position, right before the loop connecting the two β 
sheets. Curiously, mytilin K displays nine cysteines, and two of such residues are located close to the 
expected position of C5 (see Figure 3). Structural modeling shows that both cysteine residues would 
be sterically allowed to form a disulfide bond with C1, potentially producing two alternative 
structural isoforms (Figure 6F,G). 
The CCC motif found in most mytilins from Perna represents another structural peculiarity. As 
predicted by the alternate disposition of R groups in amino acid polymers, the first and the third 
residues of the triad are likely to be involved in the formation of the C2–C6 and C3–C7 disulfide 
bonds, whereas the side chain of the second cysteine residue is expected to point outwards (Figure 
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6H). Altogether, the accessibility of this side chain on the molecular surface, its unlikely involvement 
in the formation of intra-molecular disulfide bonds and the conservation of this residue in 13 out of 
the 15 Perna mytilins identified in this study, suggest that it could be engaged in an inter-molecular 
disulfide bond, resulting in the formation of homo- or heterodimers. 
Although no bivalve AMP has ever been reported to exert its antimicrobial activity as a dimer, 
a handful animal AMPs have been identified as active dimers, either stabilized by inter-molecular 
disulfide bonds, or by weak noncovalent interactions [37–40]. Clearly, while these observations pave 
the way to new hypotheses concerning the mode of action of mussel CS-αβ AMPs, the possibility that 
Perna mytilins may act as dimers will require experimental validation through the isolation of the 
native peptides from the hemocytes. 
 
Figure 6. Panel A: super-imposition of the structural models obtained for T. hirsuta mytilin 1, 2 and 
3. Panels B and C: structural models of Perna mytilins characterized by the presence of a canonical 
and an alternative cysteine array, respectively; the variable position of the C1–C5 disulfide bond is 
highlighted in red. Panels D and E schematic organization of the disulfide bond topology of mytilins 
with a canonical and alternative cysteine array, respectively. Panels F and G: alternative structural 
variants for M. galloprovincialis mytilin K, with two different sterically allowed C1–C5 disulfide bonds, 
highlighted in red. Panel H: structural model of a Perna defensin, with the side chain of the central 
cysteine residue of the CCC motif pointing outwards, highlighted in red. 
The structural predictions also allowed us to investigate more in detail the electrostatic potential 
distribution on the molecular surface of the mytilin mature peptides (Figure 7). The cationic nature 
of the canonical mytilins from Mytilus and Trichomya spp. (panels A and B), as well as for 
pseudomytilins (panel C) was well-evident, with a nearly uniform distribution of positive charges 
across the entire molecular surface, which was in line with the isoelectric point plots obtained from 
the analysis of primary sequence data (Table 1 and Figure 4). On the other hand, as mentioned in 
Section 2.2, Perna mytilins generally displayed a weaker positive net charge, to the point that a few 
mature peptides showed a nearly neutral charge (Table 1). This was quite notable, for example, in the 
case of P. canaliculus mytilin 1 (Figure 7D). It can be expected that this feature may possibly result in 
a lower binding affinity towards the negatively charged bacterial cell membranes, with a consequent 
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decreased antimicrobial potential. Whether this unusual electrostatic potential distribution is linked 
with the acquisition of alternative cytokine-like functions, as in the case of myticins, remains to be 
investigated [7]. 
 
Figure 7. Ribbon structural models and electrostatic potential of five mytilins, displayed on the 
molecular surface of the molecules, rotated on the three main axes. Panel A: T. hirsuta mytilin 2. Panel 
B: M. galloprovincialis mytilin L. Panel C: M. galloprovincialis pseudomytilin 2. Panel D: P. canaliculus 
mytilin 1. Panel E: P. viridis mytilin 5. 
3. Materials and Methods 
3.1. Identification of Mytilin Sequences 
Sequencing reads and—where available—reference transcriptomes from the studied species 
(Bathymodiolus azoricus, Bathymodiolus childressi, Bathymodiolus manusensis, B. platifrons, Bathymodiolus 
puteoserpentis, Geukensia demissa, Lithophaga lithophaga, Modiolus kurilensis, Modiolus modiolus, M. 
philippinarum, Mytilisepta virgata, M. californianus, M. chilensis, M. coruscus, M. edulis, M. 
galloprovincialis, M. planulatus, M. trossolus, P. canaliculus, P. viridis, Perumytilus purpuratus and T. 
Antibiotics 2020, 9, 37 13 of 17 
hirsuta) were downloaded from NCBI SRA and TSA databases, as reported in (Supplementary Table 
S3). 
The transcriptome assemblies for the collected reads were performed separately for each target 
species, using two distinct methods, i.e., Trinity v2.8.6 [41] and the CLC Genomics Workbench v12.0.1 
(https://www.qiagenbioinformatics.com/), in order to investigate and solve potential misassembly 
issues through the comparison between the two methodologies. Moreover, the fully sequenced and 
annotated genomes of L. fortunei [27], M. philippinarum and B. platifrons [26] were downloaded and 
included in the workflow. 
All transcriptomes and genomes were used to generate BLAST databases. Known mytilin and 
pseudomytilin sequences from M. coruscus [21] and M. galloprovincialis [4,10,42] were used to build a 
seed sequence list that was used as a query in a tBLASTn search against such databases, with an e-
value threshold of 1 × 10−3. The resulting transcriptome hits were then checked for the presence of 
complete open reading frames (ORFs), which were translated and aligned with the sequences 
included in the seed list, along with mussel defensins and myticins, in order to (i) confirm their 
classification within the mytilin family and (ii) allow their discrimination from the other two mussel 
CS-αβ AMP families. A similar process was used for genome hits, but in this case existing exon 
annotations were used to predict ORFs and to obtain the putative encoded proteins. Each verified hit 
was then added to the seed sequence list and this process was re-iterated until no new significant hits 
could be found in the screened genomes and transcriptomes. 
3.2. Primary Sequence Analysis 
All the detected mytilin-like sequences were analyzed with SignalP v4.1 [43] to identify the 
signal peptide cleavage site and aligned using MUSCLE [44]. This process, through the alignment 
with M. galloprovincialis mytilin B, whose precursor structure had been previously characterized [17], 
also enabled the identification of the putative cleavage site for the C-terminal anionic extension. The 
charge distribution of each peptide was analyzed through the calculation of the average isoelectric 
point based on a sliding window of 15 amino acids. 
3.3. Construction of a Mytilin-Specific Hidden Markov Model 
The complexity of the full set of mytilin-like sequences was reduced by removing redundant 
data. This was achieved by building a pairwise blosum 62 [45] distance graph of all sequences and 
by iteratively removing the neighbor sequences displaying a pairwise distance lower than the 
arbitrary threshold of 0.1 (set based on preliminary trials), as described in the algorithm 2 from 
Hobohm and colleagues [46]. The resulting multiple sequence alignment was used to build a HMM 
using hmmer v3.3 [47], which was subsequently tested on a set of known mussel AMPs to evaluate 
its performance, both in terms of sensibility and specificity. 
3.4. Phylogenetic Analysis 
The same multiple sequence alignment file used for the generation of the HMM was used to 
perform a phylogenetic analysis. Briefly, the best-fitting molecular model of evolution for this 
sequence set was evaluated with ModelTest-ng v.1.6 [48], based on the corrected Akaike information 
criterion. Bayesian inference analysis was run with a Monte Carlo Markov Chain approach with 
MrBayes v3.2.7a [49,50]. Two independent analyses with four chains each were run in parallel for 2 
million generations, i.e., until the estimates of all the parameters of the model reached convergence. 
This was assessed with Tracer v1.7.1 [51], by ensuring that the effective sample size for all parameters 
reached a value >200. The resulting phylogenetic tree, constructed as a 50% majority-rule consensus 
tree, was graphically rendered using FigTree v1.4, collapsing all nodes with posterior probability 
support <0.5 [52]. 
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3.5. Structural Prediction 
The three-dimensional structural prediction of selected mature mytilin peptides was performed 
with a threading/fold-recognition approach using I-TASSER v5.1 [53–56]. In detail, the N-terminal 
end of the mature peptides was predicted based on the detection of the signal peptide cleavage site 
with SignalP v4.1 [43], and the putative C-terminal end of the mature peptide was identified based 
on the alignment with the known mature peptides previously described by other authors [17]. 
Structural modeling was performed for all the novel sequences identified in this study. The reliability 
of the structural models obtained was evaluated with the c-score and the z-score metrics, calculated 
by I-TASSER and ProSA-web, respectively [57,58]. The graphical rendering and optimization of the 
3D structures were performed with USCF Chimera v1.14 [59]. This process was carried out by fixing 
the bonds with respect with the expected disulfide connectivity and by performing energy 
minimization, followed by re-evaluation of the resulting 3D structure. 
4. Conclusions 
This study reported for the first time the presence of mytilins outside the Mytilus Linnaeus 1798 
genus, extending the taxonomical range of distribution to Perna Philipsson 1788 and Trichomya 
Ihering 1900. Our results further suggest that several additional mytilins might be found in other still 
unexplored mussel species belonging to the Mytilinae and Musculinae subfamilies, and we built a 
HMM that should streamline their detection in the future from the output of genome or transcriptome 
sequencing efforts. 
Altogether, we brought further insights into the evolution of mussel CS-αβ AMPs, revealing 
that: (i) the molecular diversity of these defense molecules is higher than previously reported and (ii) 
the mussel CS-αβ structural scaffold allows a significant degree of structural flexibility, as revealed 
by the shifting position of C5 and the corresponding modification in the topology of the C1–C5 
disulfide bond, which may link the alpha helix either with the first or with the second beta strand of 
the CS-αβ fold. 
Since our investigation has been restricted to the very few genera out of the 63 currently included 
in the family Mytilidae (i.e., only those with available -omic information), our observations suggest 
that, along with the discovery of novel AMPs in Mytilidae, the nomenclature scheme of these 
molecules might require some modification, consistently with the previously reported widespread 
inconsistencies that affect the nomenclature of CS-αβ peptides in scientific literature [60]. As a matter 
of fact, the current distinction between mytilins, myticins and defensins is likely to become more and 
more unclear and AMPs with mixed features are likely to be uncovered. 
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